Table 2.
Origin of the 224 included S. aureus isolates
| Global region (n isolates total) and country of origin | Year(s) of collection | No. of isolates | Reason to include | Genome sequenced for this study | Source |
| Africa (64) | |||||
| Cameroon | 2007 | 1 | African background ST8 | Yes | (33) |
| Cameroon | 2013 | 1 | Global USA300 | No | (17) |
| DR Congo | 2011 | 10 | African background ST8 | Yes | (65) |
| Gabon | 2005 | 1 | USA300-like | Yes | (34) |
| Gabon | 2005 | 1 | USA300-like | Yes | (37) |
| Gabon | 2008 to 2012 | 7 | African background ST8 | Yes | This study* |
| Gabon | 2009 | 4 | African background ST8 | Yes | (66) |
| Gabon | 2009 to 2012 | 4 | USA300-like | Yes | (36) |
| Gabon | 2009 to 2012 | 3 | African background ST8 | Yes | (36) |
| Gabon | 2012 | 2 | African background ST8 | No | (53) |
| Gabon | 2013 | 1 | USA300-like | Yes | (35) |
| Gabon | 2013 | 3 | African background ST8 | Yes | (35) |
| Ghana | 2011 | 1 | USA300-like | Yes | (38) |
| Ghana | 2005 | 1 | African background ST8 | Yes | This study† |
| Côte d’Ivoire | 2005 | 10 | African background ST8 | Yes | (65) |
| Madagascar | 2007 | 1 | African background ST8 | Yes | (33) |
| Mozambique | 2012 | 1 | African background ST8 | No | (53) |
| Nigeria | 2005 | 7 | African background ST8 | Yes | (67) |
| Nigeria | 2007 | 2 | Phylogeny of CC8 | Yes | (49) |
| Sierra Leone | 2013 | 1 | Global USA300 | No | (17) |
| Tanzania | 2011 | 2 | African background ST8 | No | (53) |
| Australia (14) | |||||
| Australia | 1989 | 1 | First ST8 CA-MRSA | Yes | (23) |
| Australia | 2004 to 2006 | 6 | Global ST8 diversity | Yes | (24) |
| Australia | 2003 to 2008 | 4 | Global ST8 diversity | Yes | (52) |
| Australia | 2008 to 2011 | 3 | Global ST8 diversity | Yes | This study‡ |
| Caribbean (18) | |||||
| Trinidad & Tobago | 2012 | 17 | Global ST8 diversity | Yes | (29) |
| Cuba | 2013 | 1 | Global USA300 | No | (17) |
| Europe (43) | |||||
| Austria | 2005 to 2006 | 3 | Phylogeny of CC8 | Yes | (49) |
| Denmark | 1957 to 1973 | 12 | Temporal collection | Yes | This study† |
| Germany | 2010 to 2011 | 6 | Global ST8 diversity | No | (53) |
| Germany | 2003 to 2008 | 18 | Phylogeny of CC8 | Yes | (49) |
| South America (28) | |||||
| Bolivia | 2013 | 1 | Global USA300 | No | (17) |
| Brazil | 2013 | 1 | Global USA300 | No | (17) |
| Colombia | 2006 to 2007 | 13 | USA300 NAE/SAE | No | (27) |
| Colombia | 2006 to 2007 | 2 | Global ST8 diversity | No | (27) |
| Colombia | 2013 | 6 | Global USA300 | No | (17) |
| Ecuador | 2006 | 2 | USA300 NAE/SAE | No | (27) |
| Ecuador | 2013 | 2 | Global USA300 | No | (17) |
| Uruguay | 2013 | 1 | Global USA300 | No | (17) |
| North America (United States) (57)§ | |||||
| FL, HI, IL, IN, MA, MS, MT, PA, SC, NY | 2001 to 2012 | 17 | USA300 NAE/SAE | No | (27) |
| NY | 2008 to 2011 | 17 | USA300 NAE/SAE | No | (50) |
| FL, MA, MS, TX, NY | 1999 to 2011 | 8 | Global ST8 diversity | No | (27) |
| NY | 2008 to 2010 | 7 | Global ST8 diversity | No | (50) |
| NY | 1996 | 1 | USA500 reference genome | No | (68) |
| CA | 2000 | 1 | USA300 reference genome | No | (69) |
| TX | 2003 | 1 | USA300 reference genome | No | (70) |
| Unknown | 2003, 2013 | 5 | Global USA300 | No | (17) |
*
Bacterial isolates obtained from the routine microbiology laboratory at the Albert Schweitzer Hospital in Lambaréné, Gabon.
†
Bacterial isolates were obtained from the S. aureus national surveillance unit at Statens Serum Institut, Copenhagen.
‡
Bacterial isolates were obtained from the Australian Collaborating Centre for Enterococcus and Staphylococcus, Murdoch University, Murdoch, Australia.
§
FL, Florida; HI, Hawaii; IN, Indiana; MA, Massachusetts; MS, Mississippi; MT, Montana; PA, Pennsylvania; SC, South Carolina; NY, New York; TX, Texas.